Therapeutic efficacy of methylprednisolone sodium succinate via diverse administration routes for mid- to high-frequency sudden sensorineural hearing loss

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 18

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

332

Figures (1-1)

Tables (1-6)

Sum=445

Publishing Process of This Article

Item

Count

Browse

Download

Sum=17

Jun 26, 2024 (publication date) through Jul 17, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Clin Cases. Jun 26, 2024; 12(18): 3321-3331
Published online Jun 26, 2024. doi: 10.12998/wjcc.v12.i18.3321

Table 4 Therapeutic efficacy amongst the three groups [n (%)]

^aP < 0.05, when compared with Group A.

^bP < 0.05, when compared with Group B.

^cP < 0.05, when compared with Group C.

Citation: Meng XD, Li TT, Deng LM. Therapeutic efficacy of methylprednisolone sodium succinate via diverse administration routes for mid- to high-frequency sudden sensorineural hearing loss. World J Clin Cases 2024; 12(18): 3321-3331
URL: https://www.wjgnet.com/2307-8960/full/v12/i18/3321.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i18.3321